Search Results - "van den Wollenberg, D J"
-
1
A strategy for genetic modification of the spike-encoding segment of human reovirus T3D for reovirus targeting
Published in Gene therapy (01-12-2008)“…Human Orthoreovirus Type 3 Dearing is not pathogenic to humans and has been evaluated clinically as an oncolytic agent. Its transduction efficiency and the…”
Get full text
Journal Article -
2
Replicating reoviruses with a transgene replacing the codons for the head domain of the viral spike
Published in Gene therapy (01-03-2015)“…The capacity to modify the reovirus genome facilitates generation of new therapeutic reoviruses. We describe a method for generating replication-competent…”
Get full text
Journal Article -
3
Creation of immune 'stealth' genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1
Published in Gene therapy (01-11-2003)“…A major obstacle in gene-therapy protocols is T-cell-mediated destruction of transgene-expressing cells. Therefore new approaches are needed to prevent rapid…”
Get full text
Journal Article -
4
Immunosuppression promotes reovirus therapy of colorectal liver metastases
Published in Cancer gene therapy (01-08-2006)“…Mortality due to colorectal cancer (CRC) is high and is associated with the development of liver metastases. Approximately 40% of human CRCs harbor an…”
Get full text
Journal Article -
5
Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles
Published in Cancer gene therapy (01-05-2008)“…Reovirus T3D preferentially kills tumor cells expressing Ras oncogenes and has shown great promise as an anticancer agent in various preclinical tumor models…”
Get full text
Journal Article -
6
Mammalian orthoreovirus T3D infects U-118 MG cell spheroids independent of junction adhesion molecule-A
Published in Gene therapy (01-06-2014)“…In the canonical pathway, infection of cells by the wild-type mammalian orthoreovirus Type 3 Dearing (T3D) is dependent on the interaction of the viral spike…”
Get full text
Journal Article -
7
Heterogeneous reovirus susceptibility in human glioblastoma stem-like cell cultures
Published in Cancer gene therapy (01-09-2013)“…Glioblastoma (GB) is a devastating disease for which new treatment modalities are needed. Efficacious therapy requires the removal of stem-cell like cells,…”
Get full text
Journal Article -
8
Specific tumor-cell killing with adenovirus vectors containing the apoptin gene
Published in Gene therapy (01-05-1999)“…Specificity is an essential prerequisite for cancer gene therapy. Recently we described that apoptin, a protein of 121 amino acids which is derived from the…”
Get full text
Journal Article -
9
Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer located in its coding region
Published in Blood (01-05-1995)“…Hemophilia A is caused by a deficiency of factor-VIII procoagulant (fVIII) activity. The current treatment by frequent infusions of plasma-derived fVIII…”
Get full text
Journal Article -
10
The human clotting factor VIII cDNA contains an autonomously replicating sequence consensus- and matrix attachment region-like sequence that binds a nuclear factor, represses heterologous gene expression, and mediates the transcriptional effects of sodium butyrate
Published in Molecular and Cellular Biology (01-08-1996)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
11
New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses
Published in Human gene therapy (01-09-1998)“…The presence of replication-competent adenoviruses (RCAs) in batches of replication-defective adenovirus (Ad) vectors is a major problem for the application of…”
Get more information
Journal Article -
12
Baculovirus-assisted Reovirus Infection in Monolayer and Spheroid Cultures of Glioma cells
Published in Scientific reports (15-12-2017)“…The mammalian orthoreovirus Type 3 Dearing has great potential as oncolytic agent in cancer therapy. One of the bottlenecks that hampers its antitumour…”
Get full text
Journal Article -
13
Insertion of the human cytomegalovirus enhancer into a myeloproliferative sarcoma virus long terminal repeat creates a high-expression retroviral vector
Published in Gene (08-07-1994)“…A new retroviral vector is characterized in which the enhancer in the long terminal repeat of myeloproliferative sarcoma virus (MPSV) is combined with the…”
Get more information
Journal Article